Skip to main content
. 2014 Nov 20;9(3):640–656. doi: 10.1016/j.molonc.2014.11.003

Figure 2.

Figure 2

MiR‐449a expression in human glioma tissues, GSCs and GBM cell lines. (A) MiR‐449a expression in normal brain tissues (NBTs) and human glioma tissues of different grades. Data are presented as the mean ± SD (n = 8, each group). ∗∗P < 0.01 vs. NBTs group, ##P < 0.01 vs. Grade I group, △△P < 0.01 vs. Grade II group and ††P < 0.01 vs. Grade III group. (B) MiR‐449a expression in NBTs, GBM tissues (GBMs) and glioblastoma stem cells (GSCs). Data are presented as the mean ± SD (n = 5, each group). **P < 0.01 vs. NBTs group, #P < 0.05 vs. GBMs group. (C) MiR‐449a expression in human normal astrocytes and GBM cell lines (U87 and U251). Data are presented as the mean ± SD (n = 5, each group). **P < 0.01 vs. Astrocytes group.